Oligonucleotide array-cgh identifies genomic subgroups and prognostic markers for tumor stage mycosis fungoides

Journal of Investigative Dermatology

Volumn 130, Issue 4, 2010, Pages 1126-1135

  Salgado, Rocío ^a,b   Servitje, Octavio ^c   Gallardo, Fernando ^a   Vermeer, Maarten H ^d   Ortiz Romero, Pablo L ^e   Karpova, Maria B ^f   Zipser, Marie C ^f   Muniesa, Cristina ^g   García Muret, María P ^h   Estrach, Teresa ⁱ   Salido, Marta ^a   Sánchez Schmidt, Jlia ^a   Herrera, Marta ^e   Romagosa, Vicenç ^c   Suela, Javier ^j   Ferreira, Bibiana I ^k   Cigudosa, Juan C ^k   Barranco, Carlos ^a   Serrano, Sergio ^a   Dummer, Reinhard ^f   Tensen, Cornelis P ^d   Solé, Francesc ^a   Pujol, Ramon M ^a   Espinet, Blanca ^a   more..

^a HOSPITAL DEL MAR   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^e HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^f UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^g HOSPITAL DE VILADECANS   (Spain)

^h HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

ⁱ UNIVERSITY OF BARCELONA   (Spain)

^j NIMGenetics   (Spain)

^k Centro Nacional de Investigaciones Oncológicas   (Spain)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ALLELIC IMBALANCE; ARTICLE; CANCER SURVIVAL; CHROMOSOME 10P; CHROMOSOME 17Q; CHROMOSOME 7Q; CHROMOSOME 8Q; CHROMOSOME 9P; CHROMOSOME 9Q; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DNA MICROARRAY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENOMIC INSTABILITY; HUMAN; MALE; MYCOSIS FUNGOIDES; NUMERICAL CHROMOSOME ABERRATION; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS;

BIOPSY; COMPARATIVE GENOMIC HYBRIDIZATION; GENETIC MARKERS; GENETIC TESTING; GENOMIC INSTABILITY; HUMANS; MYCOSIS FUNGOIDES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; SKIN; SURVIVAL ANALYSIS;

EID: 77949521627     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2009.306     Document Type: Article

References (44)

1. Blaveri E, Brewer JL, Roydasgupta R, Fridlyand J, DeVries S, Koppie T et al. (2005) Bladder cancer stage and outcome by array-based comparative genomic hybridization. Clin Cancer Res 11:7012-7022
2. Christopher SA, Diegelman P, Porter CW, Kruger WD (2002) Methylthioa-denosine phosphorylase, a gene frequently codeleted with p16(cdkN2a/ ARF), acts as a tumor suppressor in a breast cancer cell line. Cancer Res 62:6639-6644
3. Carbone A, Bernardini L, Valenzano F, Bottillo I, De Simone C, Capizzi R et al. (2008) Array-based comparative genomic hybridization in early stage mycosis fungoides: recurrent deletion of tumor supressor genes BCL7a, SMAC/DIABLO, and RHOF. Genes Chromosomes Cancer 47:1067-1075
4. Conde L, Montaner D, Burguet-Castell J, Tárraga J, Medina I, Al-Shahrour F et al. (2007) ISACGH: a web-based environment for the analysis of array CGH and gene expression which includes functional profiling. Nucleic Acids Res 35:W81-5
5. Criscione VD, Weinstock MA (2007) Incidence of cutaneous T-cell lymphoma in the United States, 1973-2002. Arch Dermatol 143: 854-859
6. Dreyling MH, Roulston D, Bohlander SK, Vardiman J, Olopade OI (1998) Codeletion of CDKN2 and MTAP genes in a subset of non-Hodgkin's lymphoma may be associated with histologic transformation from low-grade to diffuse large-cell lymphoma. Genes Chromosomes Cancer 22:72-78
7. Espinet B, Salido M, Pujol RM, Florensa L, Gallardo F, Domingo A et al. (2004) Genetic characterization of Sézary's syndrome by conventional cytogenetics and cross-species color banding fluorescent in situ hybridization. Haematologica 89:165-173
8. Ferreira BI, Alonso J, Carrillo J, Acquadro F, Largo C, Suela J et al. (2008a) Array CGH and gene-expression profiling reveals distinct genomic instability patterns associated with DNA repair and cell-cycle checkpoint pathways in Ewing's sarcoma. Oncogene 27:2084-2090
9. Ferreira BI, Garćia JF, Suela J, Mollejo M, Camacho FI, Carro A et al. (2008b) Comparative genome profiling across subtypes of low-grade B-cell lymphoma identifies type-specific and common aberrations that target genes with a role in B-cell neoplasia. Haematologica 93:670-679
10. Fischer TC, Gellrich S, Muche JM, Sherev T, Audring H, Neitzel H et al. (2004) Genomic aberrations and survival in cutaneous T cell lympho-mas. J Invest Dermatol 122:579-586
11. Fridlyand J, Snijders AM, Ylstra B, Li H, Olshen A, Segraves R et al. (2006) Breast tumor copy number aberration phenotypes and genomic instability. BMC Cancer 6:96
12. Gallardo F, Esteller M, Pujol RM, Costa C, Estrach T, Servitje O. (2004) Methylation status of the p15, p16 and MGMT promoter genes in primary cutaneous T-cell lymphomas. Haematologica 89:1401-1403
13. Gunnarsson R, Staaf J, Jansson M, Ottesen AM, Göransson H, Liljedahl U et al. (2008) Screening for copy-number alterations and loss of heterozygosity in chronic lymphocytic leukemia-a comparative study of four differently designed, high resolution microarray platforms. Genes Chromosomes Cancer 47:697-711
14. Karenko L, Hyytinen E, Sarna S, Ranki A (1997) Chromosomal abnormalities in cutaneous T-cell lymphoma and in its premalignant conditions as detected by G-banding and interphase cytogenetic methods. J Invest Dermatol 108:22-29
15. Karenko L, Kähkönen M, Hyytinen ER, Lindlof M, Ranki A (1999) Notable losses at specific regions of chromosomes 10q and 13q in the Sezary syndrome detected by comparative genomic hybridization. J Invest Dermatol 112:392-395
16. Karenko L, Hahtola S, Päivinen S, Karhu R, Syrjä S, Kähkönen M et al. (2005) Primary cutaneous T-cell lymphomas show a deletion or translocation affecting NAV3, the human UNC-53 homologue. Cancer Res 65:8101-8110
17. Karenko L, Sarna S, Kähkönen M, Ranki A (2003) Chromosomal abnormalities in relation to clinical disease in patients with cutaneous T-cell lymphoma: a 5-year follow-up study. Br J Dermatol 148:55-64
18. Limon J, Nedoszytko B, Brozek I, Hellmann A, Zajaczek S, iñski J et al. (1995) Chromosome aberrations, spontaneous SCE, and growth kinetics in PHA-stimulated lymphocytes of five cases with Sezary syndrome. Cancer Genet Cytogenet 83:75-81
19. Mao X, Lillington D, Scarisbrick JJ, Mitchell T, Czepulkowski B, Russell-Jones R et al. (2002) Molecular cytogenetic analysis of cutaneous T-cell lymphomas: identification of common genetic alterations in Sezary syndrome and mycosis fungoides. Br J Dermatol 147:464-475
20. Mao X, Orchard G, Lillington DM, Russell-Jones R, Young BD, Whittaker SJ. (2003) Amplification and overexpression of JUNB is associated with primary cutaneous T-cell lymphomas. Blood 101:1513-1519
21. Marcé S, Balagué O, Colomo L, Martinez A, Höller S, Villamor N et al. (2006) Lack of methylthioadenosine phosphorylase expression in mantle cell lymphoma is associated with shorter survival: implications for a potential targeted therapy. Clin Cancer Res 12:3754-3761
22. Marty M, Prochazkova M, Laharanne E, Chevret E, Longy M, Jouary T et al. (2009) Primary cutaneous T-cell lymphomas do not show specific NAV3 gene deletion or translocation. J Invest Dermatol 128:2458-2466
23. Meyer N, Kim SS, Penn LZ (2006) The Oscar-worthy role of Myc in apoptosis. Semin Cancer Biol 16:275-287
24. Mirebeau D, Acquaviva C, Suciu S, Bertin R, Dastugue N, Robert A et al. (2006) The prognostic significance of CDKN2A, CDKN2B and MTAP inactivation in B-lineage acute lymphoblastic leukemia of childhood. Results of the EORTC studies 58881 and 58951. Haematologica 91:881-885
25. Navas IC, Algara P, Mateo M, Martínez P, García C, Rodriguez JL et al. (2002) p16(INK4a) is selectively silenced in the tumoral progression of mycosis fungoides. Lab Invest 82:123-132
26. Navas IC, Ortiz-Romero PL, Villuendas R, Martínez P, García C, Gómez E et al. (2000) p16(INK4a) gene alterations are frequent in lesions of mycosis fungoides. Am J Pathol 156:1565-1572
27. Nobori T, Takabayashi K, Tran P, Orvis L, Batova A, Yu AL et al. (1996) Genomic cloning of methylthioadenosine phosphorylase: a purine metabolic enzyme deficient in multiple different cancers. Proc Natl Acad Sci USA 93:6203-6208
28. Olsen E, Vonderheid E, Pimpinelli N, Willemze R, Kim Y, Knobler R et al. (2007) Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC). Blood 110:1713-1722
29. Pinkel D, Segraves R, Sudar D, Clark S, Poole I, Kowbel D et al. (1998) High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nat Genet 20:207-211
30. Pinkel D, Albertson DG (2005) Array comparative genomic hybridization and its applications in cancer. Nat Genet 37:S11-7
31. Prochazkova M, Chevret E, Mainhaguiet G, Sobotka J, Vergier B, Belaud-Rotureau MA et al. (2007) Common chromosomal abnormalities in mycosis fungoides transformation. Genes Chromosomes Cancer 46:828-838
32. Rouveirol C, Stransky N, Hupé P, Rosa PL, Viara E, Barillot E et al. (2006) Computation of recurrent minimal genomic alterations from array-CGH data. Bioinformatics 22:849-856
33. Scarisbrick JJ, Woolford AJ, Russell-Jones R, Whittaker SJ (2000) Loss of heterozygosity on 10q and microsatellite instability in advanced stages of primary cutaneous T-cell lymphoma and possible association with homozygous deletion of PTEN. Blood 95:2937-2942
34. Scarisbrick JJ, Woolford AJ, Russell-Jones R, Whittaker SJ (2001) Allelotyping in mycosis fungoides and Sezary syndrome: common regions of allelic loss identified on 9p, 10q, and 17p. J Invest Dermatol 117: 663-670
35. Solinas-Toldo S, Lampel S, Stilgenbauer S, Nickolenko J, Benner A, Döhner H et al. (1997) Matrix-based comparative genomic hybridization: biochips to screen for genomic imbalances. Genes Chromosomes Cancer 1997:7:399-407
36. Subhi AL, Tang B, Balsara BR, Altomare DA, Testa JR, Cooper HS et al. (2004) Loss of methylthioadenosine phosphorylase and elevated ornithine decarboxylase is common in pancreatic cancer. Clin Cancer Res 10:7290-7296
37. van Doorn R, van Kester MS, Dijkman R, Vermeer MH, Mulder AA, Szuhai K et al. (2009) Oncogenomic analysis of mycosis fungoides reveals major differences with Sezary syndrome. Blood 113:127-136
38. van Doorn R, Zoutman WH, Dijkman R, de Menezes RX, Commandeur S, Mulder AA et al. (2005) Epigenetic profiling of cutaneous T-cell lymphoma: promoter hypermethylation of multiple tumor supressor genes including BCL7a, PTPRG and p73. J Clin Oncol 23:3886-3896
39. Vermeer MH, van Doorn R, Dijkman R, Mao X, Whittaker S, van Voorst Vader PC et al. (2008) Novel and highly recurrent chromosomal alterations in Sezary syndrome. Cancer Res 68:2689-2698
40. Vita M, Henriksson M. (2006) The Myc oncoprotein as a therapeutic target for human cancer. Semin Cancer Biol 16:318-330
41. Wain EM, Mitchell TJ, Russell-Jones R, Whittaker SJ et al. (2005) Fine mapping of chromosome 10q deletions in mycosis fungoides and sezary syndrome: identification of two discrete regions of deletion at 10q23.33-24.1 and 10q24.33-25.1. Genes Chromosomes Cancer 42:184-192
42. Willemze R, Jaffe ES, Burg G, Cerroni L, Berti E, Swerdlow SH et al. (2005) WHO-EORTC classification for cutaneous lymphomas. Blood 105:3768-3785
43. Worsham MJ, Chen KM, Tiwari N, Pals G, Schouten JP, Sethi S et al. (2006) Fine-mapping loss of gene architecture at the CDKN2B (p15INK4b), CDKN2A (p14ARF, p16INK4a), and MTAP genes in head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 132:409-415
44. Zhao LY, Niu Y, Santiago A, Liu J, Albert SH, Robertson KD et al. (2006) An EBF3-Mediated transcriptional program that induces cell cycle arrest and apoptosis. Cancer Res 66:9445-9452